ATED Diagnostics, Ltd is dedicated to developing cutting-edge diagnostics for neurodegenerative diseases and then bringing them to the patient.
To realize this vision, we’ve forged strategic partnerships with Hebrew University in Israel, University of Rochester Medical Center, Johns Hopkins Medical Center, Columbia Presbyterian Hospital, University of Pennsylvania Medical Center, and Endeavor Health System in Chicago. By collaborating with prominent scientists at these institutions, we are transforming groundbreaking neuroscience research into commercially viable medical advancements.
Our initial work in neurodevelopmental disorders offered key insights, leading us to pursue Parkinson’s Disease.
Our focus is to bring the excellent work of Drs. Hermona Soreq and Daphne Atlas at Hebrew University to the clinic, and improving the diagnosis of Parkinson’s Disease. A clinical trial with our tRF test is being planned.
This work was published in the peer reviewed journal Nature Aging* and presented at the international Alzheimer’s/Parkinson conferences in Vienna (2025) and Copenhagen (2026).
*Madrer, N. et al. Nature Aging; pgs. 1-64, 4/11/2025
